Skip to content
Clinical Trials – home

Centre Hospitalier Intercommunal Toulon / La Seine-Sur-Mer

Verifiedinfo

France 54 Rue Henri Sainte Claire Deville, 83100 Toulon, France

  • 30 trials recruiting
  • Non-small cell lung cancer · Cardiac failure · Non-small cell lung cancer stage IV
  • Adults and children

About Specializations

Centre Hospitalier Intercommunal Toulon / La Seine-Sur-Mer in Toulon, France specialises in clinical trials of conditions such as Non-small cell lung cancer, Cardiac failure, Non-small cell lung cancer stage IV, Non-small cell lung cancer metastatic, and other specialisations. This site conducts important research.

Main research areas of the site

Oncology

The medical center is at the forefront of oncology research, focusing on innovative treatments for various types of cancer, including Non-Small Cell Lung Cancer (NSCLC) and breast carcinoma. The center's research aims to improve survival rates and quality of life for cancer patients through cutting-edge therapies.

  • Non-Small Cell Lung Cancer (NSCLC)
  • Breast Carcinoma
  • Prostate Cancer

By exploring novel combinations of immunotherapy and chemotherapy, the center is paving the way for more effective cancer treatments.

Cardiology

Specializing in cardiology, the center conducts research on heart failure and septic cardiomyopathy. The focus is on developing therapies that enhance cardiac function and reduce the risk of adverse cardiovascular events.

  • Heart Failure
  • Septic Cardiomyopathy

Through innovative clinical trials, the center is advancing the understanding of heart diseases and improving patient outcomes.

Gastroenterology

The center is renowned for its research in gastroenterology, particularly in the management of inflammatory bowel diseases such as Crohn's Disease and Ulcerative Colitis. The research focuses on optimizing treatment strategies to achieve better disease control.

  • Crohn's Disease
  • Ulcerative Colitis

By integrating patient education and telemonitoring, the center is enhancing the management of these chronic conditions.

Hematology

In the field of hematology, the center is dedicated to improving treatments for blood disorders, including Chronic Lymphocytic Leukemia (CLL). The research aims to develop therapies that target specific genetic mutations to improve patient outcomes.

  • Chronic Lymphocytic Leukemia (CLL)

Through rigorous clinical trials, the center is contributing to the development of personalized medicine approaches in hematology.

Neurology

The center's neurology research focuses on neonatal conditions such as hypoxic-ischaemic encephalopathy. The goal is to explore regenerative therapies that can improve neurological outcomes in affected infants.

  • Neonatal Hypoxic-Ischaemic Encephalopathy

By investigating the use of stem cell therapies, the center is at the cutting edge of neonatal neurological research.

Thrombosis and Hemostasis

Research in thrombosis and hemostasis at the center is focused on improving the management of conditions like venous thromboembolism and deep vein thrombosis. The center is exploring new anticoagulant therapies to enhance patient safety and efficacy.

  • Venous Thromboembolism
  • Deep Vein Thrombosis

Through comprehensive clinical trials, the center is advancing the treatment protocols for thrombotic disorders.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
54 Rue Henri Sainte Claire Deville83100 ToulonFrance
Recruiting now
30 trials
Conditions studied
56
Partner status
Verified

More sites in ToulonFrance

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

69 clinical trials

Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Topotecan Hydrochloride
  • Sponsor:Zai Lab (US) LLC
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Sponsor:Novo Nordisk A/S
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:BioNTech SE
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Sponsor:Pfizer Inc.
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:BNT327
  • Sponsor:BioNTech SE
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Azd5004
  • Sponsor:AstraZeneca AB
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Guselkumab
  • Sponsor:Groupe D'etude Therapeutique Des Affections Inflammatoires Du Tube Digestif
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Cemiplimab
  • Sponsor:Unicancer
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Sponsor:Novo Nordisk A/S
Countries:FranceFrance
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Ivonescimab
  • Sponsor:Groupe Oncologie Radiotherapie Tete Cou
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Cemiplimab
  • Sponsor:Intergroupe Francophone De Cancerologie Thoracique
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Intergroupe Francophone De Cancerologie Thoracique
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.